http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2363455-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2007-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b4f92547b382129ec86b3bac42436c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16cd243502b22c2a49c93d7cc2d00cf |
| publicationDate | 2009-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2363455-C1 |
| titleOfInvention | Method of using dalargin in complex therapy for crohn's disease |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, particularly to clinical gastroenterology and combination therapy for Crohn's disease by administering dalargin. For this purpose there is further intramuscular injection of a 1 mg dose of dalargin twice a day, during the active stage of the disease, in addition to complex therapy. The course lasts 20 days and repeated treatment is done after 3 months. n EFFECT: stimulation of proliferation and reparation processes in the intestinal wall, improved morphological picture 8 weeks after commencement of therapy, reduction of number of relapses and increased remission duration of the disease. n 1 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211006-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3622964-A1 |
| priorityDate | 2007-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.